T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Airlines Group
AAL
|
+$1.21B |
| 2 |
RTX Corp
RTX
|
+$1.14B |
| 3 |
PepsiCo
PEP
|
+$1.12B |
| 4 |
ASML
ASML
|
+$817M |
| 5 |
Wynn Resorts
WYNN
|
+$798M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Mastercard
MA
|
+$1.08B |
| 3 |
Qualcomm
QCOM
|
+$972M |
| 4 |
eBay
EBAY
|
+$898M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$748M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.86% |
| 2 | Consumer Discretionary | 13.55% |
| 3 | Financials | 13.21% |
| 4 | Industrials | 12.32% |
| 5 | Technology | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCI.PRA
926
DELISTED
Crown Castle International Corp.
CCI.PRA
| $38.8M | 0.01% |
384,027
+4,600
| +1% | +$460K |
|
|
LDL
927
DELISTED
Lydall, Inc.
LDL
| $38.6M | 0.01% |
1,685,770
| – | – |
|
|
DENN
928
DELISTED
Denny's
DENN
| $38.4M | 0.01% |
5,965,376
+2,213,557
| +59% | +$14.9M |
|
|
MDSO
929
DELISTED
Medidata Solutions, Inc.
MDSO
| $38.3M | 0.01% |
705,300
+385,000
| +120% | +$23.5M |
|
|
MNTA
930
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $38.2M | 0.01% |
3,279,239
-417,436
| -11% | -$7.07M |
|
931
Entegris
ENTG
$25.1B
| $38.1M | 0.01% |
3,146,952
+8,800
| +0.3% | +$103K |
|
932
American Eagle Outfitters
AEO
$2.72B
| $37.9M | 0.01% |
3,100,070
+1,818,630
| +142% | +$25M |
|
933
Aaon
AAON
$7.39B
| $37.7M | 0.01% |
3,045,375
+308,655
| +11% | +$4.09M |
|
|
PRO
934
DELISTED
PROS Holdings
PRO
| $37.7M | 0.01% |
1,196,990
-12,620
| -1% | -$458K |
|
935
Applied Industrial Technologies
AIT
$13.1B
| $37.7M | 0.01% |
780,652
-1,500
| -0.2% | -$73.7K |
|
936
Universal Logistics Holdings
ULH
$524M
| $37.6M | 0.01% |
1,301,793
-31,200
| -2% | -$893K |
|
937
Team
TISI
$101M
| $37.6M | 0.01% |
87,766
-7,653
| -8% | -$3.33M |
|
938
Vale
VALE
$58.6B
| $37.5M | 0.01% |
2,711,403
-237,550
| -8% | -$3.25M |
|
939
Liberty Media Series A
FWONA
$23.7B
| $37.5M | 0.01% |
1,614,068
+23,800
| +1% | +$569K |
|
940
Supernus Pharmaceuticals
SUPN
$2.76B
| $37.4M | 0.01% |
4,186,551
-176,249
| -4% | -$1.62M |
|
941
STRATTEC Security
STRT
$336M
| $37.4M | 0.01% |
517,990
-2,600
| -0.5% | -$155K |
|
942
Kratos Defense & Security Solutions
KTOS
$11.8B
| $37.4M | 0.01% |
4,954,742
-11,900
| -0.2% | -$92.1K |
|
|
QVCGA
943
DELISTED
QVC Group Inc Series A
QVCGA
| $37.3M | 0.01% |
31,437
+19
| +0.1% | +$22.2K |
|
|
MJN
944
DELISTED
Mead Johnson Nutrition Company
MJN
| $37.1M | 0.01% |
445,762
+19,400
| +5% | +$1.57M |
|
|
SASR
945
DELISTED
Sandy Spring Bancorp Inc
SASR
| $37.1M | 0.01% |
1,483,380
+1,400
| +0.1% | +$35.3K |
|
946
Modine Manufacturing
MOD
$10.8B
| $37M | 0.01% |
2,528,550
+145,140
| +6% | +$2M |
|
|
AVX
947
DELISTED
AVX Corporation
AVX
| $37M | 0.01% |
2,806,402
+4,000
| +0.1% | +$52.3K |
|
|
MR
948
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
| $37M | 0.01% |
1,142,841
-1,791,944
| -61% | -$62.7M |
|
|
EIGI
949
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $36.8M | 0.01% |
+2,831,000
| New | +$38.1M |
|
|
RSTI
950
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $36.8M | 0.01% |
1,534,642
+501,200
| +48% | +$12M |
|
Similar funds
T. Rowe Price Associates's Q1 2014 Portfolio in Review
As of Q1 2014, T. Rowe Price Associates held 2,567 positions worth $445B, up 2% from $436B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q1 2014 filing shows 89 new, 904 increased, 825 reduced and 68 closed positions. Its largest new stake was Liberty Global Class C: 13,695,496 shares worth $451M. The largest sale was Apple, an estimated $1.24B.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2014 buy was Liberty Global Class C: 13,695,496 shares worth $451M.
- T. Rowe Price Associates added most to American Airlines Group in Q1 2014, an estimated $1.21B increase.
- T. Rowe Price Associates's biggest Q1 2014 reduction was Apple, cutting an estimated $1.24B.
- T. Rowe Price Associates fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $200M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $445B portfolio in Q1 2014.
- T. Rowe Price Associates opened 89 new positions and closed 68 in Q1 2014.
- T. Rowe Price Associates's portfolio value rose 2% quarter-over-quarter to $445B.
Based on T. Rowe Price Associates's 13F filing for Q1 2014, filed 15 May 2014.